Jonathan Singh

Dr. Jonathan Singh

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2012 in Chemistry & Biology
Verified
Journal Article
Closed access
JFJessica J. Field
Jessica J. Field
BPBenet Pera
Benet Pera
ECEnrique Calvo
Enrique Calvo
ACAngeles Canales
Angeles Canales
DZDidier Zurwerra
Didier Zurwerra
JJosé Fernando Díaz
José Fernando Díaz

30 October 2009 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
JFJessica J. Field
Jessica J. Field
JSJonathan Singh
Jonathan Singh
AKArun Kanakkanthara
Arun Kanakkanthara
THTu’ikolongahau Halafihi
Tu’ikolongahau Halafihi
PNPeter T. Northcote
Peter T. Northcote
JMJohn H. Miller
John H. Miller

31 March 2010 in Marine Drugs
Verified
Journal Article
Open access
PDF file
JMJohn Miller
John Miller
JSJonathan Singh
Jonathan Singh
RSRamesh Subramani
Ramesh Subramani
Marine sponges are an excellent source of bioactive secondary metabolites with potential therapeutic value in the treatment of diseases. One group of compounds of particular interest is the microtubule-stabilizing agents, the most well-known compound of this group being paclitaxel (Taxol®), an anti-cancer compound isolated from the bark and leaves of the Pacific yew tree. This review focuses on two of the more recent additions to this important class of drugs, peloruside A and zampanolide, both isolated from marine sponges. Peloruside A was isolated from Mycale hentscheli collected in New Zealand coastal waters, and it already shows promising anti-cancer activity. Two other potent bioactive compounds with different modes of action but isolated from the same sponge, mycalamide A and pateamine, will also be discussed. The fourth compound, zampanolide, most recently isolated from the Tongan sponge Cacospongia mycofijiensis, has only recently been added to the microtubule-stabilizing group of compounds, and further work is in progress to determine its activity profile relative to peloruside A and other drugs of this class.

8 August 2013 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
JSJonathan Singh
Jonathan Singh
JDJonathan D. Dattelbaum
Jonathan D. Dattelbaum
JFJessica J. Field
Jessica J. Field
ZSZlatka Smart
Zlatka Smart
EWEthan F. Woolly
Ethan F. Woolly
PNPeter Northcote
Peter Northcote
The NMR-directed investigation of the New Zealand marine sponge Hamigera tarangaensis has afforded ten new compounds of the hamigeran family, and a new 13-epi-verrucosane congener. Notably, hamigeran F (6) possesses an unusual carbon–carbon bond between C-12 and C-13, creating an unprecedented skeleton within this class. In particular, the structural features of 6, hamigeran H (10) and hamigeran J (12) imply a diterpenoid origin, which has allowed the putative biogenesis of three hamigeran carbon skeletons to be proposed based on geranyl geranyl pyrophosphate. All new hamigerans exhibited micromolar activity towards the HL-60 promyelocytic leukaemic cell line, and hamigeran G also selectively displayed antifungal activity in the budding yeast Saccharomyces cerevisiae. Homozygous deletion profiling (HOP) analysis suggests Golgi apparatus function as a potential target of this unusual class of sponge-derived terpenoids.

12 February 2018 in Journal of Natural Products
Verified
Journal Article
Closed access
JMJohn Miller
John Miller
JFJessica J. Field
Jessica J. Field
AKArun Kanakkanthara
Arun Kanakkanthara
JOJeremy G. Owen
Jeremy G. Owen
JSJonathan Singh
Jonathan Singh
PNPeter Northcote
Peter Northcote

3 December 2009 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
JSJonathan Singh
Jonathan Singh
CXChun-Xiao Xu
Chun-Xiao Xu
XXXiaoming Xu
Xiaoming Xu
LWLyndon M. West
Lyndon M. West
AWAnja Wilmes
Anja Wilmes
AGArun K. Ghosh
Arun K. Ghosh